Skip to content

Genotype-related Effects of PUFA

Response to PUFA Intervention According to PPAR Genotypes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02296385
Enrollment
200
Registered
2014-11-20
Start date
2012-06-30
Completion date
2014-08-31
Last updated
2014-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

volunteers

Brief summary

To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism

Detailed description

To assess the bioefficacy of omega-3 fatty acids (provided by intake of fish oil supplements) depending on genotype of relevant factors in lipid metabolism.

Interventions

DIETARY_SUPPLEMENTTriple Strength Fish Oil

Triple Strength Fish Oil

Sponsors

Société des Produits Nestlé (SPN)
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adult between 18 and 40 years of age * BMI between 18.5 and 30 kg/m2 * Sedentary to moderate physical activity habits

Exclusion criteria

* Concomitant treatment: Consumption of dietary supplements or any medication that can affect the study outcomes * Actively smoking * Suspected abuse of alcohol or illicit drugs * Significant illness within the two weeks prior to study start or any active systemic infection or medical condition that may require treatment during the study * Known or suspected medical condition related to coagulation * Subject who cannot be expected to comply with the study procedures * Currently participating or having participated in another clinical trial during the last 4 weeks prior to beginning of this study

Design outcomes

Primary

MeasureTime frame
Changes in triglyceride levels in plasmaBaseline and 6 weeks intervention

Secondary

MeasureTime frameDescription
Assess bioefficacy of EPA and DHA supplementationBaseline and 6 weeks interventionThe bioefficacy will be evaluated by characterizing and measuring the effects on lipid metabolism, glucose metabolism and insulin resistance, and inflammatory response

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026